1
Safety Study of the Histone Deacetylase Inhibitor, CHR-3996, in Patients With Advanced Solid Tumours
Condition(s): Solid Tumor Last Updated: November 25, 2011Completed
360 Clinical Trials for: Histone Deacetylases, Page 1 of 18
Hide Studies Not Seeking New Volunteers
2
A Study of the Histone Deacetylase Inhibitor (HDACi) JNJ-26481585 in Patients With Previously Treated Stage Ib-IVa Cutaneous T-cell Lymphoma (CTCL)
Condition(s): Cutaneous T-cell Lymphoma; Histone Deacetylase Inhibitor; Lymphoma; Oncology Last Updated: May 7, 2013Active, not recruiting
3
Oral Histone Deacetylase Inhibitor 4SC-202 in Patients With Advanced Hematologic Malignancies (TOPAS)
Condition(s): Advanced Hematologic Malignancies Last Updated: April 29, 2013Recruiting
4
Panobinostat (LBH589) and Imatinib Mesylate in Treating Patients With Previously Treated Chronic Phase Chronic Myelogenous Leukemia
Condition(s): Leukemia Last Updated: November 6, 2012Recruiting
5
Study of Vorinostat Plus Capecitabine (X) and Cisplatin (P) for 1st Line Treatment of Metastatic or Recurrent Gastric Cancer
Condition(s): Gastric Cancer; Histone Deacetylase Inhibitor Last Updated: August 1, 2012Recruiting
6
A Study of the Histone-deacetylase Inhibitor JNJ-26481585 in Patients With Advanced or Refractory Leukemia or Myelodysplastic Syndrome
Condition(s): Advanced or Refractory Leukemia; Myelodysplastic Syndromes Last Updated: September 13, 2012Terminated
7
Histone Deacetylases - Gastric Cancer (HDAC-GaCa-2008)
Condition(s): Metastatic Gastric Cancer Last Updated: April 30, 2013Terminated
8
Phase II Study of Histone-deacetylase Inhibitor ITF2357 in Refractory/Relapsed Lymphocytic Leukemia
Condition(s): Chronic Lymphocytic Leukemia Last Updated: February 1, 2012Terminated
9
Safety and Tolerability of CHR-2845 to Treat Haematological Diseases or Lymphoid Malignancies
Condition(s): Hematological Disease; Lymphoid Malignancies Last Updated: November 25, 2011Completed
10
Dietary Histone Deacetylase Inhibitors (HDAC)
Condition(s): HDAC Activity Last Updated: October 18, 2012Not yet recruiting
11
Histone Deacetylase Inhibitor LBH589 in Addition to Corticosteroids in Patients With Acute Graft Versus Host Disease
Condition(s): Graft-Versus-Host Disease Last Updated: January 16, 2013Recruiting
12
Study of Valproic Acid to Treat HIV Infected Adults
Condition(s): HIV Infections Last Updated: May 11, 2012Terminated
13
Phase II Trial of the Histone-Deacetylase Inhibitor ITF2357 Followed by Mechlorethamine in Relapsed/Refractory Hodgkin's Lymphoma Patients
Condition(s): Hodgkin's Lymphoma Last Updated: January 31, 2012Completed
14
A Dose Escalation Study of the Histone Deacetylase Inhibitor (HDACi) JNJ 26481585 in Combination With VELCADE (Bortezomib) and Dexamethasone for Patients With Relapsed Multiple Myeloma
Condition(s): Multiple Myeloma Last Updated: March 1, 2013Recruiting
15
Study of Imatinib, a Platelet-derived Growth Factor Receptor Inhibitor, and LBH589, a Histone Deacetylase Inhibitor, in the Treatment of Newly Diagnosed and Recurrent Chordoma
Condition(s): Chordoma Last Updated: December 26, 2012Active, not recruiting
16
phII Study of an HDAC Inhibitor in Very High-risk Relapsed/Refractory Hodgkin's Lymphoma Patients
Condition(s): Hodgkin's Lymphoma Last Updated: February 1, 2012Terminated
17
Panobinostat in Treating Patients With Relapsed or Refractory Non-Hodgkin Lymphoma
Condition(s): Adult Nasal Type Extranodal NK/T-cell Lymphoma; Anaplastic Large Cell Lymphoma; Angioimmunoblastic T-cell Lymphoma; Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue; Hepatosplenic T-cell Lymphoma; Nodal Marginal Zone B-cell Lymphoma; Peripheral T-cell Lymphoma; Post-transplant Lymphoproliferative Disorder; Recurrent Adult Burkitt Lymphoma; Recurrent Adult Diffuse Large Cell Lymphoma; Recurrent Adult Lymphoblastic Lymphoma; Recurrent Adult T-cell Leukemia/Lymphoma; Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Grade 3 Follicular Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Mycosis Fungoides/Sezary Syndrome; Recurrent Small Lymphocytic Lymphoma; Small Intestine Lymphoma; Splenic Marginal Zone Lymphoma; Waldenstrom Macroglobulinemia Last Updated: April 2, 2013Recruiting
18
Panobinostat and Everolimus in Treating Patients With Recurrent Multiple Myeloma, Non-Hodgkin Lymphoma, or Hodgkin Lymphoma
Condition(s): Hematopoietic/Lymphoid Cancer; Adult Nasal Type Extranodal NK/T-cell Lymphoma; Anaplastic Large Cell Lymphoma; Angioimmunoblastic T-cell Lymphoma; B-cell Adult Acute Lymphoblastic Leukemia; Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue; Hepatosplenic T-cell Lymphoma; Nodal Marginal Zone B-cell Lymphoma; Post-transplant Lymphoproliferative Disorder; Primary Central Nervous System Lymphoma; Recurrent Adult Burkitt Lymphoma; Recurrent Adult Diffuse Large Cell Lymphoma; Recurrent Adult Hodgkin Lymphoma; Recurrent Adult Lymphoblastic Lymphoma; Recurrent Adult T-cell Leukemia/Lymphoma; Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma; Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Grade 3 Follicular Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Marginal Zone Lymphoma; Recurrent Mycosis Fungoides/Sezary Syndrome; Recurrent Small Lymphocytic Lymphoma; Refractory Multiple Myeloma; Splenic Marginal Zone Lymphoma; T-cell Adult Acute Lymphoblastic Leukemia; Waldenstrom Macroglobulinemia Last Updated: February 21, 2013Recruiting
19
A Pilot Study of Pivanex in Patients With Malignant Melanoma
Condition(s): Malignant Melanoma Last Updated: August 26, 2005Terminated
20
Phase I Study of Temozolomide, Valproic Acid and Radiation Therapy in Patients With Brain Metastases
Condition(s): Brain Metastases Last Updated: June 17, 2011Terminated
